RR
Rohit Ramakant Gulgule
About Rohit Ramakant Gulgule
Data last updated:
Rohit Ramakant Gulgule is a Director at Thinq Pharma-Cro Limited (since 2006). The companies operate in Pharma. Thinq Pharma-Cro Limited reported revenue of ₹62.89 Cr (FY 2025). Earlier, Rohit Ramakant Gulgule was a Director at D And O Pharmachem (India) Limited (from 2002).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Nov 2006 | 2006 | ₹62.89 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Feb 2002 | 1994 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rohit Ramakant Gulgule
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandrashekhar Shankar Nadkarni | 00780294 | Thinq Pharma-Cro Limited | Managing Director |
| Ravindra Ramakant Gulgule | 03629811 | Thinq Pharma-Cro Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Ramakant Gulgule
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Ramakant Gulgule
Rohit Ramakant Gulgule currently holds 1 directorship: Thinq Pharma-Cro Limited (Director, since 10 Nov 2006, revenue ₹62.89 Cr (FY 2025)).
Rohit Ramakant Gulgule was first appointed on 26 Feb 2002 as Director at D And O Pharmachem (India) Limited. The most recent appointment on record is 10 Nov 2006 at Thinq Pharma-Cro Limited.
Rohit Ramakant Gulgule held 1 earlier board appointment: D And O Pharmachem (India) Limited (Director, from 26 Feb 2002).
The current boards of Rohit Ramakant Gulgule's companies include Chandrashekhar Shankar Nadkarni (Thinq Pharma-Cro Limited), Ravindra Ramakant Gulgule (Thinq Pharma-Cro Limited).